Home/Pipeline/Breast Cancer Locator (BCL) System

Breast Cancer Locator (BCL) System

Breast Cancer (invasive and DCIS) for Breast Conserving Surgery (BCS)

Pivotal TrialActive

Key Facts

Indication
Breast Cancer (invasive and DCIS) for Breast Conserving Surgery (BCS)
Phase
Pivotal Trial
Status
Active
Company

About Cairn Surgical

CairnSurgical is a private, clinical-stage medical device company targeting a critical unmet need in oncology surgery: the high rate of positive tumor margins in breast-conserving surgery (BCS). Its core technology platform translates patient-specific supine MRI scans into 3D-printed physical guides (the Breast Cancer Locator) that fit the unique contour of a patient's breast, aiming to provide surgeons with precise intraoperative guidance on tumor location, size, and margins. The company is currently conducting a pivotal U.S. clinical trial to demonstrate the BCL's superiority over the standard-of-care wire localization method, with the goal of improving surgical outcomes, reducing re-operation rates, and lowering overall healthcare costs.

View full company profile

Therapeutic Areas